Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lianhua Qingke Tablet for COVID-19 Patients with Comorbidities
ChiCTR2200066183Phase 4Recruiting
- Sponsor
- Hebei Province Chest Hospital
- Start
- Nov 2022
- Countries
- 1
01
Overview
Phase 4, randomised trial of Lianhua Qingke in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by Hebei Province Chest Hospital. Primary endpoint: Disappearance rate and median time of clinical symptoms. Started Nov 2022; status: recruiting.
02
Drugs
Lianhua Qingke
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on ChiCTR2200066183.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200066183.